Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Quest Diagnostics Inc (DGX) Com Stk Usd0.01

Sell:$112.80 Buy:$112.83 Change: $0.69 (0.62%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
Sell:$112.80
Buy:$112.83
Change: $0.69 (0.62%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
Sell:$112.80
Buy:$112.83
Change: $0.69 (0.62%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Contact details

Address:
500 Plaza Dr
SECAUCUS
07094-3619
United States
Telephone:
+1 (973) 5202700
Website:
https://www.questdiagnostics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DGX
ISIN:
US74834L1008
Market cap:
$15.20 billion
Shares in issue:
133.00 million
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Stephen Rusckowski
    Chairman of the Board, President, Chief Executive Officer
  • Mark Guinan
    Chief Financial Officer, Executive Vice President
  • James Davis
    Executive Vice President, General Diagnostics
  • Gabrielle Wolfson
    Senior Vice President and Chief Information and Digital Officer
  • Michael Prevoznik
    Senior Vice President, General Counsel
  • Everett Cunningham
    Senior Vice President - Commercial
  • Catherine Doherty
    Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing
  • Carrie Manner
    Senior Vice President - Advanced Diagnostics
  • Michael Deppe
    Vice President, Corporate Controller and Chief Accounting Officer and Principal Accounting Officer
  • Manuel Mendez
    Executive Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.